The pharmacist’s role in chimeric antigen receptor T cell therapy

Autor: Julie Kennerly-Shah, Jennifer P Booth, Carolyn L Kusoski
Rok vydání: 2020
Předmět:
Zdroj: Journal of Oncology Pharmacy Practice. 26:1725-1731
ISSN: 1477-092X
1078-1552
DOI: 10.1177/1078155220948940
Popis: The emergence and efficacy of chimeric antigen receptor (CAR) T cell therapy in previously incurable malignancies represents a promising paradigm shift in cancer care. However, it is not without significant clinical, operational, and financial considerations. Pharmacists should be prepared to fulfill the various roles in CAR T cell therapy provision including: policy development; electronic medical record build; patient and staff education; patient selection; procurement, storage, and handling; medication administration and supportive care; management of adverse reactions; and quality tracking. Our commentary provides an overview of the opportunities for pharmacy involvement in the implementation and maintenance of a CAR T cell therapy program with an emphasis on the importance of pharmacy involvement as part of a multidisciplinary approach to care. Although some institutions have dedicated a CAR T cell pharmacist to meet the demands of emerging CAR T cell therapy, we believe that clinical pharmacists practicing in hematopoietic stem cell transplant and hematology/oncology have the skills and training to fulfill the pharmacist’s role in CAR T cell therapy.
Databáze: OpenAIRE